Skip to main content
. 2026 Mar 14;16(3):162. doi: 10.3390/jpm16030162
ACR American College of Rheumatology
ANOVA Analysis of Variance
ASyS Anti-Synthetase Syndrome
AV/VA Alveolar Volume
BL B-Line
CK Creatine Kinase
CTDs Connective Tissue Diseases
DAD Diffuse Alveolar Damage
DLCO Diffusing Capacity of the Lungs for Carbon Monoxide
DM Dermatomyositis
EC Examiner/Operator Initials
EULAR European Alliance of Associations for Rheumatology
FEV1 Forced Expiratory Volume in the First Second
HAQ Health Assessment Questionnaire
HRCT High-Resolution Computed Tomography
IBM Inclusion Body Myositis
IIM/IIMs Idiopathic Inflammatory Myopathies
ILD Interstitial Lung Disease
IMACS International Myositis Assessment and Clinical Studies
LCQ Leicester Cough Questionnaire
LDH Lactate Dehydrogenase
LUS/Lung US Lung Ultrasound
MAA Myositis-Associated Autoantibody
MDA5 Melanoma Differentiation-Associated Protein 5
MMT8 Manual Muscle Test (8 Muscles)
MRC Medical Research Council
MSA Myositis-Specific Autoantibody
MYOACT Myositis Disease Activity Assessment Tool
NPV Negative Predictive Value
NSIP Non-Specific Interstitial Pneumonia
NXP-2 Nuclear Matrix Protein 2
OMERACT Outcome Measures in Rheumatology
OP Organizing Pneumonia
PFTs Pulmonary Function Tests
PIs Pleural Irregularities
PM Polymyositis
PPV Positive Predictive Value
PRO Patient Reported Outcome
RA Rheumatoid Arthritis
ROC Receiver Operating Characteristic
SB Second Operator Initials(iniziali)
SD Standard Deviation
SGRQ Saint George Respiratory Questionnaire
SLE Systemic Lupus Erythematosus
SSc Systemic Sclerosis
SRP Signal Recognition Particle
TIF1γ Transcription Intermediary Factor 1-gamma
TLC Total Lung Capacity
UIP Usual Interstitial Pneumonia
US Ultrasound
VAS Visual Analog Scale
VC Vital Capacity
WS Warrick Score